Close

CFRA Downgrades Bristol-Myers Squibb Co. (BMY) to Sell

May 1, 2022 3:33 PM EDT
Get Alerts BMY Hot Sheet
Price: $74.78 +0.85%

Rating Summary:
    13 Buy, 14 Hold, 4 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 5 | Down: 15 | New: 12
Join SI Premium – FREE

CFRA downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Hold to Sell with a price target of $66.00.


For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.


Shares of Bristol-Myers Squibb Co. closed at $77.20 yesterday.


You May Also Be Interested In





Related Categories

Downgrades